Overview

Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia

Status:
Completed
Trial end date:
2002-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine how Olanzapine compares to an active comparator in the treatment of schizophrenia
Phase:
Phase 4
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Olanzapine